Company Filing History:
Years Active: 2008
Title: Pachiappan Manickam: Innovator in Tumor Suppressor Gene Research
Introduction
Pachiappan Manickam is a notable inventor based in Huntsville, AL (US). He has made significant contributions to the field of genetics, particularly in the discovery of a novel tumor suppressor gene associated with multiple endocrine neoplasia type 1. His work has implications for both diagnostics and gene therapy.
Latest Patents
Pachiappan Manickam holds 1 patent. His patent relates to the identification of a gene designated MEN1, which encodes the protein menin. The absence of this protein and mutations in the MEN1 gene have been linked to individuals suffering from multiple endocrine neoplasia type 1. This discovery has opened avenues for diagnostic applications and potential gene therapy solutions.
Career Highlights
Pachiappan Manickam is affiliated with the National Institutes of Health, a component of the US Department of Health & Human Services. His research has been pivotal in understanding the genetic underpinnings of endocrine disorders. His work continues to influence the field of medical genetics and cancer research.
Collaborations
Pachiappan has collaborated with esteemed colleagues such as Settara Chandrasekharappa and Siradanahalli Guru. Their combined expertise has furthered research in the area of tumor suppressor genes and their implications in health.
Conclusion
Pachiappan Manickam's innovative research in tumor suppressor genes exemplifies the critical role of genetics in understanding and treating complex diseases. His contributions are invaluable to the scientific community and have the potential to impact patient care significantly.